Skip to content

Category: Programme 1 – ThARGET

SIRIC ILIAD shares the progress of its research with its partners | Review 2020-2021

The SIRIC ILIAD Partners’ Committee met on 31 August to present its 2020-2021 results. On August 31, 2021, the fourth
Lire la suite >

SIRIC ILIAD partners with the Multimodal Imaging Centre of the Grand-Ouest: IMRAM

As a result of a partnership between Nantes University Hospital and the Western Cancer Institute (ICO), the new shared medical
Lire la suite >

Workshop: Adaptation of the tumour and its ecosystem to radiotherapies | September 22nd-25th, 2021 – Le Bono, West of France

The SIRIC ILIAD partner event organised by the “Tumour targeting, Imaging, radiotherapies network” of the Cancéropôle Grand-Ouest, is dedicated to
Lire la suite >

Clinical trial: 89 Zr TLX250 Immuno-PET Cohort

OPALESCENCE : 89 Zr TLX250 Immuno-PET Cohort Type of study : Single-centre study Pathology : Metastatic triple negative breast cancer
Lire la suite >

Archives 2018-2022